Environmental drivers of the spatiotemporal dynamics of
respiratory syncytial virus in the United States.
Percentage of reported
respiratory syncytial virus (RSV) cases, by patient age group and polymerase chain reaction (PCR) test positivity--Arizona, 2013-14 through 2016-17 RSV seasons Age group (yrs) RSV season <5 5-14 15-64 2013-14 Total no.
Epidemiology and prevention of
respiratory syncytial virus infections among infants and young children.
Respiratory syncytial virus infections have a severe course in high-risk populations.
O'Brien et al., "Global, regional, and national disease burden estimates of acute lower respiratory infections due to
respiratory syncytial virus in young children in 2015: a systematic review and modelling study," The Lancet, vol.
Severe
respiratory syncytial virus bronchiolitis in infancy and asthma and allergy by age 13 years.
Three known types of influenza viruses (A, B, and C) currently circulate in the human population, Types A and B are associated with clinically important respiratory illness.4
Respiratory syncytial virus (RSV) is best known for its tendency to cause bronchiolitis in infants, but it can infect all age groups causing upper and lower respiratory tract infections ranging in severity from subclinical infections to pneumonia and death.5
Key words:
Respiratory syncytial virus, Bronchiolitis, Hospitalizations, Puerto Rico
Respiratory syncytial virus (RSV), seasonal influenza viruses and human metapneumovirus (hMPV) are among the most common viruses that cause respiratory infections in humans.
Globally,
respiratory syncytial virus (RSV) is one of the major causes of childhood acute lower respiratory infection (ALRI) associated morbidity, hospitalization, and mortality.